Hyponatremia: Difference between revisions
| (19 intermediate revisions by 4 users not shown) | |||
| Line 36: | Line 36: | ||
**[[Dysphagia]] | **[[Dysphagia]] | ||
**[[Dysarthria]] | **[[Dysarthria]] | ||
**[[Paresis]] | **[[Weakness|Paresis]] | ||
==Differential Diagnosis of '''Hypotonic''' Hyponatremia (by Volume Status)== | ==Differential Diagnosis of '''Hypotonic''' Hyponatremia (by Volume Status)== | ||
===Hypovolemic=== | ===Hypovolemic=== | ||
====Renal Causes==== | ====Renal Causes==== | ||
*Thiazide diuretic use | *Thiazide [[diuretic]] use | ||
*Na-wasting | *Na-wasting nephropathy ([[renal tubular acidosis|RTA]], CKD) | ||
*Osmotic diuresis (glucose, urea) | *Osmotic diuresis ([[hyperglycemia|glucose]], urea) | ||
*Aldosterone deficiency | *Aldosterone deficiency | ||
====Extra-renal Causes==== | ====Extra-renal Causes==== | ||
*GI loss | *GI loss | ||
| Line 67: | Line 68: | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*Drugs<ref>Review of Drug-Induced Hyponatremia. Am J Kidney Dis 2008;52:144</ref><ref>Kate M, Grover S. Bupropion-Induced Hyponatremia. General Hospital Psychiatry Volume 35, Issue 6, November–December 2013, 681-683.</ref> | *Drugs<ref>Review of Drug-Induced Hyponatremia. Am J Kidney Dis 2008;52:144</ref><ref>Kate M, Grover S. Bupropion-Induced Hyponatremia. General Hospital Psychiatry Volume 35, Issue 6, November–December 2013, 681-683.</ref> | ||
**[[NSAIDs]], [[ | **[[NSAIDs]], [[sulfonylurea]], [[bupropion]] | ||
*H<sub>2</sub>0 intoxication | *H<sub>2</sub>0 intoxication | ||
*Glucocorticoid deficiency | *[[Adrenal insufficiency|Glucocorticoid deficiency]] | ||
===Pseudohyponatremia=== | ===Pseudohyponatremia=== | ||
*Hyperglycemia | *[[Hyperglycemia]] | ||
**Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref name="Hillier">Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403</ref> | **Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref name="Hillier">Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403</ref> | ||
*Displaced sodium in lab specimen | *Displaced sodium in lab specimen | ||
**Hyperlipidemia | **[[Hypertriglyceridemia|Hyperlipidemia]] | ||
**Hyperproteinemia | **Hyperproteinemia | ||
| Line 83: | Line 84: | ||
*Urine | *Urine | ||
**[[Urinalysis]] | **[[Urinalysis]] | ||
**Urine electrolytes | **Urine electrolytes (Urine sodium) | ||
**Urine urea | **Urine urea | ||
**urine uric acid | **urine uric acid | ||
| Line 89: | Line 90: | ||
**urine creatinine | **urine creatinine | ||
*Serum | *Serum | ||
**Chemistry | **Chemistry including Ca/Mg/Phos | ||
**Serum osmolality | **Serum osmolality | ||
**Uric acid | **Uric acid | ||
| Line 117: | Line 118: | ||
==General Management== | ==General Management== | ||
''Must have sufficient confidence that the symptoms are '''caused''' by hyponatraemia'' | ''Must have sufficient confidence that the symptoms are '''caused''' by hyponatraemia; see Clinical Features for definition of categories.'' | ||
===Severe | ===NOT Severe/Moderately-Severe (Including Asymptomatic)=== | ||
'''Adults:<ref name="Spasovski" />''' | '''Adults:<ref name="Spasovski" />''' | ||
# | #Start prompt diagnostic assessment and provide cause-specific treatment | ||
#Check serum sodium concentration after | #Check serum sodium concentration after 4 hours | ||
# | #*Aim for a 5 mmol/l per 24-h increase in serum sodium concentration | ||
#*Limit increase to 10 mmol/l in the first 24 h (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached | |||
#* | #Manage the patient as in moderately-severe symptomatic hyponatraemia if the serum sodium concentration decreases 10 mmol/l | ||
# | |||
===Moderately Severe Symptoms=== | ===Moderately Severe Symptoms=== | ||
| Line 140: | Line 138: | ||
#Manage the patient as in severely symptomatic hyponatraemia if the serum sodium concentration further decreases despite treating the underlying diagnosis (2D). | #Manage the patient as in severely symptomatic hyponatraemia if the serum sodium concentration further decreases despite treating the underlying diagnosis (2D). | ||
=== | ===Severe Symptoms=== | ||
'''Adults:<ref name="Spasovski" />''' | '''Adults:<ref name="Spasovski" />''' | ||
# | #3% hypertonic saline 150 mL bolus over 20 min | ||
#Check serum sodium concentration after | #Check serum sodium concentration after 20 min | ||
# | #Repeat infusion of 150 ml 3% hypertonic saline for the next 20 min | ||
#* | #Repeat twice or until a target of 5 mmol/l increase in serum sodium concentration is achieved | ||
# | #*Each 100 mL will raise sodium by ~2 mmol/l | ||
#*In general, 200-400 mL of 3% hypertonic saline is reasonable dose in most adult patients with severe symptomatic hyponatremia, which may be given IV over 1-2 hr until resolution of seizures. | |||
#If you do not have 3% hypertonic saline you can give two ampules (100ml) of crash cart hypertonic bicarbonate (1 mEq/ml sodium bicarbonate equivalent to giving ~200 ml of 3% saline, which will raise the serum sodium by ~3 mM)<ref>[https://emcrit.org/ibcc/hyponatremia/ Josh Farkas IBCC Hyponatremia]</ref>. | |||
#*Sodium bicarbonate should be given slowly (each ampule over 5-10 minutes). Bicarbonate is contraindicated in patients with metabolic alkalosis. | |||
'''Pediatrics:<ref>Moritz ML, Ayus JC. 100cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010 Mar; 25(1): 91-6.</ref>''' | |||
*2 mL/kg of 3% over 10-60 minutes can be infused with a repeat of up to 3 times. | |||
==Cause-Specific Treatment== | ==Cause-Specific Treatment== | ||
| Line 195: | Line 198: | ||
| 3% Saline||513 mEq/L | | 3% Saline||513 mEq/L | ||
|} | |} | ||
==[[DDAVP]] Combined with Hypertonic Saline== | |||
*Limited evidence suggests usage of [[DDAVP]] in combination with HTS can safely increase sodium, while lowering risk for over-correction<ref>Sood L et al. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013 Apr;61(4):571-8.</ref> | |||
**DDAVP prevents free water excretion renally | |||
**Give 3% hypertonic saline based on calculations above | |||
**Give [[desmopressin]] 1-2 µg IV q6 hours | |||
**Patients must be PO water restricted | |||
*Goal sodium is 6 mEq/L over first 24 hours | |||
==Disposition== | ==Disposition== | ||
| Line 201: | Line 212: | ||
==See Also== | ==See Also== | ||
*[[Electrolyte | *[[Electrolyte abnormalities]] | ||
*[[Osmotic demyelination syndrome]] | *[[Osmotic demyelination syndrome]] | ||
==External Links== | ==External Links== | ||
*[https://emcrit.org/ibcc/hyponatremia/ IBCC Hyponatremia Josh Farkas] | |||
*[http://emcrit.org/podcasts/hyponatremia/ EMCrit Hyponatremia Management] | |||
*[http://ddxof.com/electrolyte-abnormalities/ DDxOf: Differential Diagnosis of Electrolyte Abnormalities] | *[http://ddxof.com/electrolyte-abnormalities/ DDxOf: Differential Diagnosis of Electrolyte Abnormalities] | ||
*[https://emcrit.org/pulmcrit/taking-control-of-severe-hyponatremia-with-ddavp/ PulmCrit DDAVP Clamp] | |||
==References== | ==References== | ||
Latest revision as of 07:06, 15 February 2020
Background
- Defined as sodium concentration <135meq/L[1]
- Patients often not symptomatic until <120meq/L, although this level varies by patients and may be higher if the change occurred abruptly[2]
- Too fast of sodium correction (>10 mmol/L/day), especially if chronic, can cause osmotic demyelination syndrome (central pontine myelinolysis)[3]
Clinical Features
Hyponatremia Symptoms by Severity[2]
| Severity | NOT severe | Moderately severe | Severe |
| Symptoms |
|
Symptoms from Rapid Correction of Sodium
- CHF
- Osmotic demyelination syndrome (central pontine myelinolysis)
Differential Diagnosis of Hypotonic Hyponatremia (by Volume Status)
Hypovolemic
Renal Causes
- Thiazide diuretic use
- Na-wasting nephropathy (RTA, CKD)
- Osmotic diuresis (glucose, urea)
- Aldosterone deficiency
Extra-renal Causes
- GI loss
- 3rd space loss
- Burns
- Pancreatitis
- Peritonitis
Hypervolemic
- Urinary Na >20
- Urinary Na <20
Euvolemic
- SIADH
- urine sodium is greater than 20-40 mEq/L
- Pain, stress, nausea
- Psychogenic polydipsia
- Hypothyroidism
- Drugs[4][5]
- H20 intoxication
- Glucocorticoid deficiency
Pseudohyponatremia
- Hyperglycemia
- Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL[6]
- Displaced sodium in lab specimen
- Hyperlipidemia
- Hyperproteinemia
Evaluation
Work-Up
Prior to giving treatment
- Urine
- Urinalysis
- Urine electrolytes (Urine sodium)
- Urine urea
- urine uric acid
- urine osmolality
- urine creatinine
- Serum
- Chemistry including Ca/Mg/Phos
- Serum osmolality
- Uric acid
- TSH
- Cortisol
Diagnosis
- Correct for glucose (see table)
- Determine volume status
- Calculated osm (in true hyponatremia the osm is reduced)
Hypertonic Hyponatremia
Defined as osmolarity > 295mmol/L with the following causes:
- Hyperglycemia
- Sodium decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL[6]
- Mannitol excess
Isotonic (pseudo) hyponatremia
Defined as osmolarity > 275-295mmol/L. Often referred to as pseudo hyponatremia because the elevated lipids or proteins interfere with the laboratory sodium reading. The following are common causes:
- Hyperlipidemia
- Hyperproteinemia
Hypotonic Hyponatremia
Defined as an osmolarity < 275 mmol/L and categorized as hypovolemic, hypervolemic or euvolemic
General Management
Must have sufficient confidence that the symptoms are caused by hyponatraemia; see Clinical Features for definition of categories.
NOT Severe/Moderately-Severe (Including Asymptomatic)
Adults:[2]
- Start prompt diagnostic assessment and provide cause-specific treatment
- Check serum sodium concentration after 4 hours
- Aim for a 5 mmol/l per 24-h increase in serum sodium concentration
- Limit increase to 10 mmol/l in the first 24 h (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached
- Manage the patient as in moderately-severe symptomatic hyponatraemia if the serum sodium concentration decreases 10 mmol/l
Moderately Severe Symptoms
Adults:[2]
- 3% hypertonic saline 150 mL bolus over 20 min
- Start prompt diagnostic assessment and provide cause-specific treatment
- Check serum sodium concentration after 1, 6 and 12 hours
- Aim for a 5 mmol/l per 24-h increase in serum sodium concentration
- Limit increase to 10 mmol/l in the first 24 h (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached
- Consider DDAVP (2mcgs IV q8h) to prevent overcorrection
- Manage the patient as in severely symptomatic hyponatraemia if the serum sodium concentration further decreases despite treating the underlying diagnosis (2D).
Severe Symptoms
Adults:[2]
- 3% hypertonic saline 150 mL bolus over 20 min
- Check serum sodium concentration after 20 min
- Repeat infusion of 150 ml 3% hypertonic saline for the next 20 min
- Repeat twice or until a target of 5 mmol/l increase in serum sodium concentration is achieved
- Each 100 mL will raise sodium by ~2 mmol/l
- In general, 200-400 mL of 3% hypertonic saline is reasonable dose in most adult patients with severe symptomatic hyponatremia, which may be given IV over 1-2 hr until resolution of seizures.
- If you do not have 3% hypertonic saline you can give two ampules (100ml) of crash cart hypertonic bicarbonate (1 mEq/ml sodium bicarbonate equivalent to giving ~200 ml of 3% saline, which will raise the serum sodium by ~3 mM)[7].
- Sodium bicarbonate should be given slowly (each ampule over 5-10 minutes). Bicarbonate is contraindicated in patients with metabolic alkalosis.
Pediatrics:[8]
- 2 mL/kg of 3% over 10-60 minutes can be infused with a repeat of up to 3 times.
Cause-Specific Treatment
Hypertonic hyponatremia
- Correct underlying disorder which is often hyperglycemia[9]
- Often volume depleted due to osmotic diuresis and normal saline provides adequate volume repletion
Isotonic (pseudo) hyponatremia
- No treatment needed [9]
Hypotonic hyponatremia
- Hypovolemic
- Give normal saline, but be cautious of raising the serum sodium more than 10 mmol/L/day and causing osmotic demyelination syndrome (central pontine myelinolysis)[10]
- Euvolemic[9]
- Water restrict
- Treat underlying cause
- Hypervolemic
- Water restriction
- Diuresis
- Treat underlying cause
Calculating Sodium Replacement Therapy
Max correction 10mEq/L in first 24hr (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached (lowers risk of osmotic demyelination syndrome) [10]
Step 1
Calculate total body water[11]
- TBW(kg) = Wt(kg) x 0.6 = [Wt(lb) x 0.45] x 0.6 = Wt(lb) x 0.27
Step 2
Calculate mEq deficit
- (Desired Na - Measured Na) ~ must be ≤ 10
Step 3
Calculate NS rate to be given over 24hr
- NS rate (cc/hr) = TBW x mEq deficit x 0.27
- If using 3% sodium chloride (to avoid volume overload) divide above rate by 3.33
| Fluid type | Sodium Concentration |
| 1/2 Normal Saline | 77 mEq/L |
| Normal Saline | 154 mEq/L |
| Lactated Ringers | 130 mEq/L |
| 3% Saline | 513 mEq/L |
DDAVP Combined with Hypertonic Saline
- Limited evidence suggests usage of DDAVP in combination with HTS can safely increase sodium, while lowering risk for over-correction[12]
- DDAVP prevents free water excretion renally
- Give 3% hypertonic saline based on calculations above
- Give desmopressin 1-2 µg IV q6 hours
- Patients must be PO water restricted
- Goal sodium is 6 mEq/L over first 24 hours
Disposition
- Admit if symptomatic or if Na <125mEq/L
- Manage severely symptomatic patients in "an environment where close biochemical and clinical monitoring can be provided" (e.g. ICU)
See Also
External Links
- IBCC Hyponatremia Josh Farkas
- EMCrit Hyponatremia Management
- DDxOf: Differential Diagnosis of Electrolyte Abnormalities
- PulmCrit DDAVP Clamp
References
- ↑ Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Seminars in Nephrology 2009 29 227–238
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Spasovski et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 0: 1–39. fulltext
- ↑ Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9.
- ↑ Review of Drug-Induced Hyponatremia. Am J Kidney Dis 2008;52:144
- ↑ Kate M, Grover S. Bupropion-Induced Hyponatremia. General Hospital Psychiatry Volume 35, Issue 6, November–December 2013, 681-683.
- ↑ 6.0 6.1 Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403
- ↑ Josh Farkas IBCC Hyponatremia
- ↑ Moritz ML, Ayus JC. 100cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010 Mar; 25(1): 91-6.
- ↑ 9.0 9.1 9.2 Schrier RW, Bansal S. Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care 2008;14:627-34
- ↑ 10.0 10.1 Nagler EV1, Vanmassenhove J, van der Veer SN et al. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med. 2014 Dec 11;12:1
- ↑ The hyponatremia formulas do not work so well (Clin J Am Soc Nephrol 2007;2:1110 and Nephrol Dial Transplant 2006;21:1564)
- ↑ Sood L et al. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013 Apr;61(4):571-8.
